Switzer TV

 

Welcome back for another year of stock picks, top LICs and trading tips with Switzer Investing TV. Good to have you aboard.

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

In this first show of the year, Peter Switzer sits down with Adam Dawes from Shaw and Partners, Mike Gable from Fairmont Equities, and Paul Rickard from the Switzer Report to cut through the noise.

They run the ruler over some of the market’s most talked-about names, including CSL, NextDC, Xero, WiseTech, Pro Medicus, lithium plays, uranium stocks, and gold. Fundamentals meet charts, sentiment clashes with valuation, and the panel doesn’t always agree. You’ll hear why great businesses can fall a long way without anything being “wrong”, what the charts are really saying about beaten-up tech, why resources have momentum again, and whether gold is still a defensive play with upside in 2026.

Switzer Investing TV (19/12/25): Are these smashed stocks worth your time?

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

More videos

Mad about Money Live

Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.

Series:
3 hot value stocks + CEO of iSelect, buy or not & house price boom to die?

Roger Montgomery from Montgomery Investment Management, Warren Hebard from iSelect, Michael Knox from Morgans and Paul Rickard from Switzer join the show.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for the latest live episode of Mad about Money.

Series:
It’s time to hunt for value stocks, try these: CSL, RMD, BHP, WPL + BHP a buy?

Peter Switzer speaks to Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard from Switzer.

Series:
Basal cancer and the treatments that have risen due to COVID-19

Dr Ross Walker discusses research on basal cell cancer treatment that is similar to the COVID-19 vaccine.

Series:
6 top stocks from fund manager and broker + house price boom exaggerated?

Prime Value Asset Management's ST Wong, Morgans' Raymond Chan, Century 21's Charles Tarbey and Coolabah Capital's Ying Yi Ann Cheng join Peter Switzer.

Series:
Mad about Money Live

Peter Switzer and Paul Rickard discuss the big money stories of the day and how they will affect you.

Series:
Graham Kelly from Noxopharm Limited (ASX:NOX)

Peter Switzer speaks to Graham Kelly, the founder, CEO and managing director of Noxopharm (NOX).

Series:
Stocks being dumped that are long term buys: CSL, DMP, JBH & 4 great income stocks

Burman Invest's Julia Lee, Tribeca's Jun Bei Liu, Switzer's Paul Rickard and Spacetalk's Mark Fortunatow join the show.

Series:
The benefits of drinking coffee and tea every day

Last week Dr Ross told us what happens when diabetics have coffee and tea every day, but what are the benefits for non-diabetics?

Series:
Hot tech stocks – MP1, NXL + could stocks fall 10%? & CEO of Aussie Home Loan

Peter Switzer is joined by Michael Wayne from Medallion Financial Group, Kieran Davies from Coolabah Capital and James Symond from Aussie Home Loans.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for our latest live episode of Mad about Money.

Series:
1 33 34 35 36 37 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram